Cargando…
In situ breast cancer incidence patterns in Iceland and differences in ductal carcinoma in situ treatment compared to Sweden
The purpose was to review the incidence of in situ carcinoma in Iceland after initiating population-based mammography screening in 1987 and to compare management of ductal carcinoma in situ (DCIS) between Iceland and the Uppsala–Örebro region (UÖR) in Central Sweden. The Icelandic Cancer Registry pr...
Autores principales: | Agustsson, Arnar S., Birgisson, Helgi, Agnarsson, Bjarni A., Jonsson, Thorvaldur, Stefansdottir, Hrefna, Wärnberg, Fredrik, Lambe, Mats, Tryggvadottir, Laufey, Sverrisdottir, Asgerdur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7572374/ https://www.ncbi.nlm.nih.gov/pubmed/33077767 http://dx.doi.org/10.1038/s41598-020-74134-5 |
Ejemplares similares
-
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
por: Jonasson, Jon G, et al.
Publicado: (2016) -
The behaviour of metals in deep fluids of NE Iceland
por: Saby, Marion, et al.
Publicado: (2022) -
Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers
por: Aradottir, Margret, et al.
Publicado: (2014) -
BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
por: Stefansson, Olafur A, et al.
Publicado: (2019) -
A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
por: Zhou, Wenjing, et al.
Publicado: (2013)